These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25677901)

  • 1. Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer.
    Yang J; Xiong X; Wang X; Guo B; He K; Huang C
    Tumour Biol; 2015 Jul; 36(7):5109-18. PubMed ID: 25677901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
    Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
    PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screen and identification of serum protein biomarkers in gastric cancer].
    Zhang H; Li H; Guo F; Zhang D; Yang H; Wang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Mar; 19(3):317-22. PubMed ID: 27003656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
    Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
    J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression and clinical significance of serum protein among patients with clear-cell renal cell carcinoma.
    Nuerrula Y; Rexiati M; Liu Q; Wang YJ
    Cancer Biomark; 2015; 15(4):485-91. PubMed ID: 26406868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum peptide mapping in gastric precancerous lesion and cancer.
    Li P; Ma D; Zhu ST; Tang XD; Zhang ST
    J Dig Dis; 2014 May; 15(5):239-45. PubMed ID: 24438315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.
    Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z
    Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.
    Liu W; Liu B; Cai Q; Li J; Chen X; Zhu Z
    Clin Chim Acta; 2012 Jul; 413(13-14):1098-106. PubMed ID: 22446497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer.
    Yang L; Tang C; Xu B; Wang W; Li J; Li X; Qin H; Gao H; He K; Song S; Liu X
    PLoS One; 2015; 10(6):e0128970. PubMed ID: 26047516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
    Tsunemi S; Nakanishi T; Fujita Y; Bouras G; Miyamoto Y; Miyamoto A; Nomura E; Takubo T; Tanigawa N
    Oncol Rep; 2010 Apr; 23(4):949-56. PubMed ID: 20204278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel serum biomarkers for gastric cancer by magnetic bead.
    Liu W; Gao X; Cai Q; Li J; Zhu Z; Li C; Yao X; Yang Q; Xiang M; Yan M; Zhu Z
    Front Biosci (Elite Ed); 2010 Jun; 2(3):961-71. PubMed ID: 20515767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry.
    Hara T; Honda K; Ono M; Naito K; Hirohashi S; Yamada T
    J Urol; 2005 Oct; 174(4 Pt 1):1213-7. PubMed ID: 16145372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of biomarkers in the serum of the patients with poorly differentiated gastric cancer].
    Li W; Liu BY; Li JF; Chen XH; Hao JH; Cai Q; Gu QL; Zhu ZG; Lin YZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):253-6. PubMed ID: 16721691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
    Mohri Y; Mohri T; Wei W; Qi YJ; Martin A; Miki C; Kusunoki M; Ward DG; Johnson PJ
    Br J Cancer; 2009 Jul; 101(2):295-302. PubMed ID: 19550422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics.
    Qiu FM; Yu JK; Chen YD; Jin QF; Sui MH; Huang J
    J Exp Clin Cancer Res; 2009 Sep; 28(1):126. PubMed ID: 19740432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.
    Song Y; Xu X; Wang N; Zhang T; Hu C
    J Clin Lab Anal; 2022 Apr; 36(4):e24254. PubMed ID: 35212031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics analysis of human serum of patients with non-small-cell lung cancer reveals proteins as diagnostic biomarker candidates.
    Boccellino M; Pinto F; Ieluzzi V; Giovane A; Quagliuolo L; Fariello C; Coppola M; Carlucci A; Santini M; Ferati K; Bexheti-Ferati A; Giordano A; Di Domenico M
    J Cell Physiol; 2019 Dec; 234(12):23798-23806. PubMed ID: 31180588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of α1-antitrypsin as a potential prognostic biomarker for advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors by proteomic analysis.
    Zhao W; Yang Z; Liu X; Tian Q; Lv Y; Liang Y; Li C; Gao X; Chen L
    J Int Med Res; 2013 Jun; 41(3):573-83. PubMed ID: 23613495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
    Gianazza E; Chinello C; Mainini V; Cazzaniga M; Squeo V; Albo G; Signorini S; Di Pierro SS; Ferrero S; Nicolardi S; van der Burgt YE; Deelder AM; Magni F
    J Proteomics; 2012 Dec; 76 Spec No.():125-40. PubMed ID: 22868251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.